| 词条 | Aminooxyacetic acid |
| 释义 |
| Verifiedfields = changed | Watchedfields = changed | verifiedrevid = | ImageFile = Aminooxyacetic Acid.svg | ImageSize = | IUPACName = 2-(aminooxy)acetic acid | OtherNames = Carboxymethoxylamine Hydroxylamineacetic acid U-7524 |Section1={{Chembox Identifiers | IUPHAR_ligand = 5136 | ChEMBL_Ref = {{ebicite|correct|EBI}} | ChEMBL = 347862 | StdInChI_Ref = {{stdinchicite|correct|chemspider}} | StdInChI = 1S/C2H5NO3/c3-6-1-2(4)5/h1,3H2,(H,4,5) | StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | StdInChIKey = NQRKYASMKDDGHT-UHFFFAOYSA-N | InChI = 1/C2H5NO3/c3-6-1-2(4)5/h1,3H2,(H,4,5) | InChIKey = NQRKYASMKDDGHT-UHFFFAOYAB | CASNo_Ref = {{cascite|correct|??}} | CASNo = 645-88-5 | PubChem = 286 | ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | ChemSpiderID = 280 | UNII_Ref = {{fdacite|changed|FDA}} | UNII = 14I68GI3OQ | SMILES = O=C(O)CON | DrugBank_Ref = {{drugbankcite|correct|drugbank}} | DrugBank = DB02079 | SMILES2 = NOCC(O)=O | MeSHName = Aminooxyacetic+Acid |Section2={{Chembox Properties | Formula = C2H5NO3 | MolarMass = 91.066 | Appearance = | Density = 1.375 g/cm3 | MeltingPtC = 138 | BoilingPtC = 326.7 | Solubility = |Section3={{Chembox Hazards | MainHazards = | FlashPtC = 151 | AutoignitionPtC = }}Aminooxyacetic acid, often abbreviated AOA or AOAA, is a compound that inhibits 4-aminobutyrate aminotransferase (GABA-T) activity in vitro and in vivo, leading to less gamma-aminobutyric acid (GABA) being broken down.[1] Subsequently, the level of GABA is increased in tissues. At concentrations high enough to fully inhibit 4-aminobutyrate aminotransferase activity, aminooxyacetic acid is indicated as a useful tool to study regional GABA turnover in rats.[2] Aminooxyacetic acid is a general inhibitor of pyridoxal phosphate (PLP)-dependent enzymes (this includes GABA-T).[3] It functions as an inhibitor by attacking the Schiff base linkage between PLP and the enzyme, forming oxime type complexes.[3] Aminooxyacetic acid inhibits aspartate aminotransferase, another PLP-dependent enzyme, which is an essential part of the malate-aspartate shuttle.[5] The inhibition of the malate-aspartate shuttle prevents the reoxidation of cytosolic NADH by the mitochondria in nerve terminals.[4] Also in the nerve terminals, aminooxyacetic acid prevents the mitochondria from utilizing pyruvate generated from glycolysis, thus leading to a bioenergetic state similar to that of hypoglycemia.[4] Aminooxyacetic acid has been shown to cause excitotoxic lesions of the striatum, similar to Huntington's disease, potentially due to its impairment of mitochondrial energy metabolism.[5] Aminooxyacetic acid was previously used in a clinical trial to reduce symptoms of Huntington's disease by increasing GABA levels in the brain.[6] However, the patients who received the aminooxyacetic acid treatment failed to show clinical improvement and suffered from side effects such as drowsiness, ataxia, seizures, and psychotic behavior when the dosage was increased beyond 2 mg per kilogram per day.[6] Also, the inhibition of aspartate aminotransferase by aminooxyacetic acid has clinical implications for the treatment of breast cancer, since a decrease in glycolysis disrupts breast adenocarcinoma cells more than normal cells.[7] Moreover, selective inhibition of aspartate aminotransferase with aminooxyacetic acid ameliorated experimental autoimmune encephalomyelitis in a therapeutic mouse model by reprograming the differentiation of pro-inflammatory T helper 17 cells, that boost the immune system, towards induced anti-inflammatory regulatory T cells.[8] Aminooxyacetic acid has been studied as a treatment for tinnitus.[9][10][11] One study showed that about 20% of patients with tinnitus had a decrease in its severity when treated with aminooxyacetic acid.[11] However, about 70% of those patients reported side effects, mostly nausea and disequilibrium.[11] Thus, the investigators of the study concluded that the incidence of the side effects makes aminooxyacetic acid unsuitable to treat tinnitus.[11] Aminooxyacetic acid also has anticonvulsant properties.[12] At high dosages, it can act as a convulsant agent in mice and rats.[13] Aminooxyacetic acid can also inhibit 1-aminocyclopropane-1-carboxylate synthase preventing ethylene synthesis, which can increase the vase life of cut flowers.[14][15] HistoryAminooxyacetic acid was first described by Werner in 1893, and was prepared by the hydrolysis of ethylbenzhydroximinoacetic acid.[16][17][18][19] In 1936, Anchel and Shoenheimer used aminooxyacetic acid to isolate ketones from natural sources.[18] Also in 1936, Kitagawa and Takani described the preparation of aminooxyacetic acid by the condensation of benzhydroxamic acid and ethyl bromoacetate, followed by hydrolysis by hydrochloric acid.[20] References1. ^{{Cite journal | last1 = Wallach | first1 = D. | title = Studies on the GABA pathway. I. The inhibition of gamma-aminobutyric acid-alpha-ketoglutaric acid transaminase in vitro and in vivo by U-7524 (amino-oxyacetic acid) | journal = Biochemical Pharmacology | volume = 5 | issue = 4 | pages = 323–331 | year = 1961 | pmid = 13782815 | doi=10.1016/0006-2952(61)90023-5}} {{GABA receptor modulators}}{{Glutamate metabolism and transport modulators}}2. ^{{cite journal |author1=Wolfgang Löscher |author2=Dagmar Hönack |author3=Martina Gramer | year = 1989 | title = Use of Inhibitors of γ-Aminobutyric Acid (GABA) Transaminase for the Estimation of GABA Turnover in Various Brain Regions of Rats: A Reevaluation of Aminooxyacetic Acid | journal = Journal of Neurochemistry | volume = 53 | issue = 6 | pages = 1737–1750 | doi = 10.1111/j.1471-4159.1989.tb09239.x | pmid = 2809589 | url = | format = | accessdate = }} 3. ^1 {{Cite journal | last1 = Beeler | first1 = T. | last2 = Churchich | first2 = J. | title = Reactivity of the phosphopyridoxal groups of cystathionase | journal = Journal of Biological Chemistry | volume = 251 | issue = 17 | pages = 5267–5271 | year = 1976 | pmid = 8458}} 4. ^1 2 {{cite journal |author1=Risto A. Kauppinen |author2=Talvinder S. Sihra |author3=David G. Nicholls | year = 1987 | title = Aminooxyacetic acid inhibits the malate-aspartate shuttle in isolated nerve terminals and prevents the mitochondria from utilizing glycolytic substrates | journal = Biochimica et Biophysica Acta | volume = 930 | issue = 2 | pages = 173–178 | doi = 10.1016/0167-4889(87)90029-2| pmid = 3620514 }} 5. ^{{Cite journal | last1 = Beal | first1 = M. | last2 = Swartz | first2 = K. | last3 = Hyman | first3 = B. | last4 = Storey | first4 = E. | last5 = Finn | first5 = S. | last6 = Koroshetz | first6 = W. | title = Aminooxyacetic acid results in excitotoxin lesions by a novel indirect mechanism | journal = Journal of Neurochemistry | volume = 57 | issue = 3 | pages = 1068–1073 | year = 1991 | pmid = 1830613 | doi=10.1111/j.1471-4159.1991.tb08258.x}} 6. ^1 {{Cite journal | last1 = Perry | first1 = T. | last2 = Wright | first2 = J. | last3 = Hansen | first3 = S. | last4 = Allan | first4 = B. | last5 = Baird | first5 = P. | last6 = MacLeod | first6 = P. | title = Failure of aminooxyacetic acid therapy in Huntington disease | journal = Neurology | volume = 30 | issue = 7 Pt 1 | pages = 772–775 | year = 1980 | pmid = 6446691 | doi=10.1212/wnl.30.7.772}} 7. ^{{Cite journal | last1 = Thornburg | first1 = J. M. | last2 = Nelson | first2 = K. K. | last3 = Clem | first3 = B. F. | last4 = Lane | first4 = A. N. | last5 = Arumugam | first5 = S. | last6 = Simmons | first6 = A. | last7 = Eaton | first7 = J. W. | last8 = Telang | first8 = S. | last9 = Chesney | first9 = J. | doi = 10.1186/bcr2154 | title = Targeting aspartate aminotransferase in breast cancer | journal = Breast Cancer Research | volume = 10 | issue = 5 | pages = R84 | year = 2008 | pmid = 18922152 | pmc = 2614520}} 8. ^{{Cite journal | last1 = Xu | first1 = T. | last2 = Kelly | first2 = M. | last3 = et | first3 = all. | title = Metabolic control of TH17 and induced Treg cell balance by an epigenetic mechanism | journal = Nature | year = 2017 | doi=10.1038/nature23475}} 9. ^{{Cite journal | last1 = Reed | first1 = H. | last2 = Meltzer | first2 = J. | last3 = Crews | first3 = P. | last4 = Norris | first4 = C. | last5 = Quine | first5 = D. | last6 = Guth | first6 = P. | title = Amino-oxyacetic acid as a palliative in tinnitus | journal = Archives of Otolaryngology | volume = 111 | issue = 12 | pages = 803–805 | year = 1985 | pmid = 2415097 | doi=10.1001/archotol.1985.00800140047008}} 10. ^{{Cite journal | last1 = Blair | first1 = P. | last2 = Reed | first2 = H. | title = Amino-oxyacetic acid: A new drug for the treatment of tinnitus | journal = Journal of the Louisiana State Medical Society | volume = 138 | issue = 6 | pages = 17–19 | year = 1986 | pmid = 3734755}} 11. ^1 2 3 {{Cite journal | last1 = Guth | first1 = P. | last2 = Risey | first2 = J. | last3 = Briner | first3 = W. | last4 = Blair | first4 = P. | last5 = Reed | first5 = H. | last6 = Bryant | first6 = G. | last7 = Norris | first7 = C. | last8 = Housley | first8 = G. | last9 = Miller | first9 = R. | title = Evaluation of amino-oxyacetic acid as a palliative in tinnitus | journal = The Annals of Otology, Rhinology, and Laryngology | volume = 99 | issue = 1 | pages = 74–79 | year = 1990 | pmid = 1688487}} 12. ^{{Cite journal | last1 = Davanzo | first1 = J. | last2 = Greig | first2 = M. | last3 = Cronin | first3 = M. | title = Anticonvulsant properties of amino-oxyacetic acid | journal = American Journal of Physiology | volume = 201 | pages = 833–837 | year = 1961 | pmid = 13883717}} 13. ^{{Cite journal | last1 = Wood | first1 = J. | last2 = Peesker | first2 = S. | title = The role of GABA metabolism in the convulsant and anticonvulsant actions of aminooxyacetic acid | journal = Journal of Neurochemistry | volume = 20 | issue = 2 | pages = 379–387 | year = 1973 | pmid = 4698285 | doi=10.1111/j.1471-4159.1973.tb12137.x}} 14. ^{{Cite journal | last1 = Broun | first1 = R. | last2 = Mayak | first2 = S. | title = Aminooxyacetic acid as an inhibitor of ethylenesynthesis and senescence in carnation flowers | journal = Scientia Horticulturae | volume = 15 | issue = 3 | pages = 277–282 | year = 1981 | doi = 10.1016/0304-4238(81)90038-8}} 15. ^{{cite journal|last1=Zuliana |first1=R. |last2=Boyce |first2=A. N. |last3=Nair |first3=H. |last4=Chandran |first4=S. |year=2008 |title=Effects of aminooxyacetic acid and sugar on the longevity of pollinated Dendrobium Pompadour |journal=Asian Journal of Plant Sciences |volume=7 |issue=7 |pages=654–659 |url=http://www.scialert.net/pdfs/ajps/2008/654-659.pdf |accessdate=2011-05-18 |doi=10.3923/ajps.2008.654.659 }}{{dead link|date=July 2017 |bot=InternetArchiveBot |fix-attempted=yes }} 16. ^{{cite journal |last=Werner|first=A. |year=1893 |title=Ueber Hydroxylaminessigsäure und Derivate derselben |journal=Berichte der deutschen chemischen Gesellschaft |volume=26 |issue=2 |pages=1567–1571 |doi=10.1002/cber.18930260274}} 17. ^{{cite journal |last1=Werner|first1=A. |last2=Sonnenfeld|first2=E. |year=1894 |title= Ueber Hydroxylaminessigsäure und α-Hydroxylaminpropionsäure |journal=Berichte der deutschen chemischen Gesellschaft |volume=27|issue=3 |pages=3350–3354|doi=10.1002/cber.189402703141}} 18. ^1 {{cite journal |last1=Anchel |first1=Marjorie |last2=Schoenheimer |first2=Rudolf |year=1936 |title= Reagents for the isolation of carbonyl compounds from unsaponifiable material |journal=Journal of Biological Chemistry |volume=114 |pages=539–546|url=http://www.jbc.org/content/114/2/539.full.pdf |accessdate=2011-05-20 |issue=2}} 19. ^{{cite journal |author1=Borek, E. |author2=Clarke, H. T. | year = 1936 | title = Carboxymethoxylamine | journal = Journal of the American Chemical Society | volume = 58 | issue = 10 | pages = 2020–2021 | doi = 10.1021/ja01301a058 | url = | format = | accessdate = }} 20. ^{{cite journal |title=Studies on a Diamino Acid, Canavanin, IV. The Constitution of Canavanin and Canalin|last1=Kitagawa|first1=Matsunosuke |last2=Takani|first2=A. |year=1936|journal=Journal of Biochemistry |volume=23|pages=181–185}} 2 : GABA transaminase inhibitors|Glutamate decarboxylase inhibitors |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。